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Current in vitro cell culture studies of viral replication deliver detailed time courses of
several virological variables, like the amount of virions and the number of target cells,
measured over several days of the experiment. Each of these time points solely provides
a snap-shot of the virus infection kinetics and is brought about by the complex interplay
of target cell infection, and viral production and cell death. It remains a challenge to
interpret these data quantitatively and to reveal the kinetics of these underlying processes
to understand how the viral infection depends on these kinetic properties. In order to
decompose the kinetics of virus infection, we introduce a method to “quantitatively”
describe the virus infection in in vitro cell cultures, and discuss the potential of the
mathematical based analyses for experimental virology.
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INTRODUCTION
The recent rapid development of experimental techniques in
molecular biology and cell biology has revealed many new
insights into the complexed interactions between viruses and
their target cells. Most of these studies are of a qualitative nature
and describe the cellular andmolecular details of the interactions.
To learn more about the quantitative features of virus replica-
tion, we can now generate time courses tracking the dynamics of
viruses and target cells in experiments. Each of the time points
during a series of experiment provides a snap-shot of the num-
ber of target cells, the number of infected cells, and the amount
of virions in the culture. The whole time course reflects the
results of a complex process consisting of consecutive interac-
tions between viruses, their target cells, infected cells, and viral
production. It is difficult to translate these data quantitatively
into the parameters identifying the multi-composed kinetics of
viral infection. To decompose and quantify the kinetics of virus
infection, it will be an extremely useful to rely on mathemati-
cal modeling, mathematical analysis, and numerical simulation
of the experimental data (Ho et al., 1995; Perelson et al., 1997).
Modeling the whole time courses mathematically, we can esti-
mate several parameters underlying the kinetics of virus infection
(e.g., the burst size and the basic reproductive number). These
parameters cannot be obtained directly by experiments only.
Comparing the parameter values between viruses allows one to
identify the major functional differences between viruses, and to
understand why one is more virulent than the other, and why
their time courses are so different. This approach is particularly
useful for analyzing data from in vitro experiments using cell
cultures, because we can nowadays obtain frequent samples of
several kinetic variables in a relatively simple environment (as
compared to an in vivo infection). Indeed, it is now possible to
fully parameterize our mathematical models on such in vitro data,
and to realize quite robust quantification of the virus infection
kinetics (Mohler et al., 2005; Beauchemin et al., 2008; Iwami et al.,
2012).
The importance and significance of modeling work is slowly
becoming recognized in the community of experimental virolo-
gists. Starting with the landmark papers revealing the turnover of
HIV-1 infected cells in vivo from the decline in the viral load in
patients following initiation of antiretroviral therapy (Ho et al.,
1995; Wei et al., 1995), mathematical modeling has evolved into
an important tool in modern biology (Perelson, 2001). Here we
introduce our recently developed approach to “quantitatively”
describe the kinetics of virus infection in cell cultures employing
the full time-course of the data. And we will discuss the potential
of such approaches combining experimental and mathematical
analyses to address unsolved question in virology by identifying
viral parameters.
MATERIALS AND METHODS
In vitro cell culture experimental data on the infection of HSC-F
cells with SHIV-KS661 were collected over time courses of 10
consecutive days. Each day most of virus (85.4%), and a small
percentage of the cells (5.5%) was removed from the culture
supernatant for measurement, and fresh medium was added.
The measurement consisted of the concentrations of HSC-F
cells positive or negative for a viral antigen, Nef, [cells/ml],
and the SHIV-KS661viral load [RNA copies/ml] (Table 1). The
experiment was repeated for two different values of the initial
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Table 1 | Experimental data for the in vitro experiment.
MOI Measurement day
0 1 2 3 4 5 6 7 8 9
CONCENTRATION OF Nef-NEGATIVE HSC-F CELLS (cells/ml)
2 × 10−4 6400000 6570000 6240000 4795608 4826259 1234110 463638 156560 40843 16200
2 × 10−5 6400000 7300000 7690000 5790000 5233650 6005620 2404116 575240 231420 123641
CONCENTRATION OF Nef-POSITIVE HSC-F CELLS (cells/ml)
2 × 10−4 d.l. d.l. d.l. 15392 483741 1865890 866362 223440 69157 13800
2 × 10−5 d.l. d.l. d.l. d.l. 36350 424380 3315884 1394760 468580 46359
TOTAL VIRAL LOAD OF SHIV-KS661 (RNA copies/ml)
2 × 10−4 150096 2110000 12000000 322000000 7090000000 26000000000 23400000000 8430000000 1560000000 511000000
2 × 10−5 16439 160814 621353 17700000 362000000 2180000000 21600000000 21300000000 9000000000 2360000000
d.l., designates samples in which the concentration was below the detection limit.
viral inoculum (MOI: multiplicity of infection). The time courses
were analyzed with the model described below.
VIRUS INFECTION
The virus solution of SHIV-KS661 (Shinohara et al., 1999) was
prepared in a CD4+ human T lymphoid cell line, M8166 (a sub-
clone of C8166) (Clapham et al., 1987), and was stored in liquid
nitrogen until use. The HSC-F cell line (Akari et al., 1996) was
cultured in a culture medium (RPMI-1640 supplemented with
10% fetal calf serum) at 37◦C and 5% CO2 in humidified condi-
tions. Each experiment was performed using 2 wells of a 24-well
plate with a total suspension volume of 2ml (1ml per well) and
an initial cell concentration of T0 = 6.46 × 106 cells/ml in each
well. Because the initial cell concentration is close to the carry-
ing capacity of 24-well plates, and HSC-F cells replicate slowly,
in the absence of SHIV-KS661 infection, the population of tar-
get cells, changes very little on the timescale of our experiment
(data not shown). We therefore neglected the effects of potential
regeneration of HSC-F cells when constructing the mathemat-
ical model. For virus infection, cultures of HSC-F cells were
inoculated with two different MOIs [MOI 2.0 × 10−4 and MOI
2.0 × 10−5, where aMOI of 1means one 50% tissue culture infec-
tious dose (TCID50) per cell] of SHIV-KS661, and were incubated
at 37◦C. Four hours after inoculation, the cells were washed to
remove the remaining viruses and were replaced into a fresh cul-
ture medium. The culture supernatant was harvested daily for 10
days, and was replaced with fresh medium. On a daily basis 5.5%
of the cells in the culture were harvested tomeasure the number of
target cells and infected cells. Cells were counted by staining them
with an anti-SIV Nef monoclonal antibody (04–001, Santa Cruz
Biotechnology, Santa Cruz, CA) labeled by ZenonAlexa Fluor 488
(Invitrogen, Carlsbad, CA), as previously described (Iwami et al.,
2012). Each harvested supernatant, including 85.4% of the cul-
ture virus was stored at −80◦C, and the amount of viral RNA
was quantified by RT-PCR, as previously described (Iwami et al.,
2012).
MATHEMATICALMODELING
To describe the in vitro kinetics of virus infection, we used a
classical mathematical model that is used widely for analyzing
viral kinetics (Perelson and Nelson, 1999; Nowak and May, 2000;
Perelson, 2001):
dT
dt
= −βTV, dI
dt
= βTV − δI, dV
dt
= pI − cV, (1)
where T and I are the numbers of target (susceptible) cells, and
infected (virus-producing) cells per ml of medium, respectively,
and V is the number of RNA copies of virus per ml of medium.
The parameters δ, c, β and p represent the death rate of infected
cells, the degradation rate of viral RNA, the rate constant for
infection of target cells by virus, and the viral production rate
of an infected cell, respectively. The basic model (1) is a sim-
plified version of the previously developed mathematical model
in (Iwami et al., 2012), because we here use the time-course
data including only viral RNA (but not both viral RNA and
infectivity). A schematic of the basic model is shown in Figure 1.
DATA FITTING
Due to the daily harvesting of cells and virus, in our model
the concentrations of target and infected cells must be reduced
by 5.5% per day, and the viral loads (RNA copies) have to be
reduced by 85.4% per day.We approximate these losses by adding
FIGURE 1 | A schematic representation of the mathematical model.
The variables T and I are the number of target and infected cells,
respectively, and V is the number of RNA copies of virus. The parameters δ,
c, β and p represent the death rate of infected cells, the degradation rate of
viral RNA, the rate constant for infection of target cells by virus, and the
viral production rate of an infected cell, respectively.
Frontiers in Microbiology | Virology September 2012 | Volume 3 | Article 319 | 2
Iwami et al. Identifying viral parameters
continuous exponential decay terms, −dT, −dI, and −rV , to
the equations, respectively, where d = 0.057 per day to account
for the harvesting of cells, and r = 1.93 per day for the collec-
tion of virus. The degradation rate of virus was estimated to
be c = 0.039 per day in separate experiments (data not shown).
The remaining three parameters (δ, β, p), along with the 6 ini-
tial (t = 0) values for the variables (three for each of the two
MOI values), were determined by fitting Equation (1) to the
data. We simultaneously fit Equation (1) to the concentrations
of Nef-negative and Nef-positive HSC-F cells and the viral loads
for both MOIs, using nonlinear least-squares regression [using
the FindMinimum package of Mathematica8.0 that minimizes
the sum of squared residuals (SSR)]. Experimental measure-
ments below the detection limit were excluded when computing
the SSR.
RESULTS AND DISCUSSION
In total we obtained 53 data points for quantifying the kinetics of
SHIV-KS661 in vitro cell cultures. Using a previously established
estimate for the degradation rates of RNA (c) in vitro culture, we
estimated the values of the three remaining unknown parame-
ters (δ, β, p) and the six initial values. The parameter estimates
obtained by fitting Equation (1) to the full in vitro dataset simul-
taneously as described in “Materials and Methods” are given in
Tables 2 and 3. These estimates are similar to our previous param-
eter estimates in (Iwami et al., 2012). The behavior of the model
using these best-fit parameter estimates is shown together with
the data in Figure 2, which reveals that the relatively simple model
of Equation (1) describes these in vitro data very well. This sug-
gests that the parameters that were estimated are representative
for the various processes underlying the viral kinetics. Let us
discuss what we can learn from these data.
HALF-LIFE OF INFECTED CELLS (log2/δ)
The death rate of infected cells was estimated to be δ = 1.75 per
day. Since in differential equations the time to death is expo-
nentially distributed (Holder and Beauchemin, 2011), this death
rate corresponds to a half-life of log 2/δ = 0.40d, and an average
life-span of 1/δ = 0.57 d, of productively infected HSC-F cells.
Because the Nef protein is primarily produced at a late phase of
the viral replication in a cell, and since we do not distinguish
between an early eclipse phase and a late phase of virus produc-
tion in our model, the “infected cells” that our model describes
should largely correspond to cells at a relatively late stage of
infection (Iwami et al., 2012). The half-life that we estimate
should therefore apply primarily for infected cells at a late stage of
infection, and need not apply for cells in the early eclipse phase.
BURST SIZE (p/δ)
The viral production rate of an infected cell was estimated to be
p = 3.26 × 104 RNA copies per day. Because an infected cell in
the model produces virus over an average of 1/δ days, the total
viral burst size can be estimated as p/δ = 1.87 × 104 RNA copies
per cell. This in vitro estimate is in reasonable agreement with
recent in vivo estimates obtained using single-cycle SIV (Chen
et al., 2007). The total burst size is defined as the total number
of virions produced by any one infected cell during its life-time
(Nowak and May, 2000; Beauchemin et al., 2008; Iwami et al.,
2012) (see Figure 3), and is often considered as a normalized
viral replication property reflecting the trade-off between viral
production (p) and its cytopathic effects (δ).
BASIC REPRODUCTIVE NUMBER (R0)
The average number of newly infected cells produced from any
one infected cell, under conditions where the most of the target
cells are uninfected, is known as the basic reproductive number
R0, and is an important parameter predicting the course of infec-
tion (Nowak et al., 1997; Nowak and May, 2000; Ribeiro et al.,
2010). Any one infected cell produces a progeny of p/(δ + d)
viruses before the cell dies, or is removed from the culture, and
each produced virus will infect target cells at a constant rate β,
until the virus is cleared or harvested (i.e., over 1/(r + c) days
on average). At the beginning of the experiment there are T0 tar-
get cells. Thus, using our parameter estimates, the reproductive
number is calculated as R0 = βpT0/[(δ + d)(r + c)] = 5.10 in
in vitro culture experiments (Nowak and May, 2000; Beauchemin
et al., 2008; Iwami et al., 2012) (see Figure 3). The basic repro-
ductive number characterizes the course of the infection in cell
Table 3 | Fitted initial values for the in vitro experiment.
Variable Unit Fitted initial value at MOI of
2× 10−4 2× 10−5
T(0) cells/ml 8.36 × 106 8.18 × 106
I(0) cells/ml 1.13 3.45 × 10−4
V(0) RNA copies/ml 1.50 × 105 1.41 × 104
Table 2 | Parameters values and derived quantities.
Parameter Name Symbol Unit Value
PARAMETERS OBTAINED FROM SIMULTANEOUS FIT TO FULL in vitro DATASET
Rate constant for infection β (RNA/ml · day)−1 8.61 × 10−11
Death rate of infected cells δ day−1 1.75
Production rate of total virus p RNA copies · day−1 3.26 × 104
QUANTITIES DERIVED FROM FITTED VALUES
Half-life of infected cells log 2/δ days 0.40
Viral burst size p/δ RNA copies 1.87 × 104
Basic reproductive number of virus R0 – 5.10
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FIGURE 2 | The mathematical model describes the data well. HSC-F
cells were inoculated with SHIV-KS661 24h before t = 0 and each in vitro
experimental quantity was measured daily from t = 0 d to 9 d. The curves
depict the best fit of the model (Equation 1), to the experimental data of
SHIV-KS661 infection in vitro (symbols) for the target cells, infected cells,
and the viral load for the two different experiments conducted at different
MOIs. All data were fitted simultaneously as described in “Materials and
Methods.”
FIGURE 3 | The burst size and the basic reproductive number of a
virus. The burst size is defined as the expected number of virions produced
by one infected cell over its life-time (e.g., p/δ = 9 in the figure). The basic
reproductive number, R0, is defined as the expected number of newly
infected cells resulting from one infected cell during its life-time
(e.g., R0 = 6 in the figure).
culture. For example, one can predict the fraction of target cells
that will be removed by the infection through the recursive rela-
tion 1 − f I = e−R0 fI , which is called the “final size equation”
(Anderson, 1991; Iwami et al., 2012). Here the parameter fI corre-
sponds to the fraction of target cells that are eventually removed
by the infection (i.e., fI = 1 − T(∞)/T0). Using the R0 = 5.1 we
find that fI = 0.9937, and that the fraction of surviving target cells
at the end of the infection should approach 1-fI = 0.0063. In our
experiments this implies a final target cell population of approx-
imately T (∞) = 4.03 × 104 cells/ml. This value agrees well with
the final size of Nef-negative HSC-F cells in the MOI 2.0 × 10−4
experiment, where T (9) = 1.62 × 104 cells/ml. Thus, the basic
reproductive number provides valuable information about the
expected course of infection. Note that at the MOI of 2.0 × 10−5
the infection is so slow that the final target cell value has not yet
been approached at day 9 (see Figure 2).
CONCLUSION
Combining mathematical modeling with experimental data, we
have been able to estimate several parameters defining the kinetics
of SHIV-KS661 infecting HSC-F cells, from just two time courses
of an in vitro infection. For this it was essential that we had the
full time-course of the infection available for fitting the model.
The data before the peak of virus infection, i.e., the up-slope
of the number of viral RNA copies in the culture supernatant,
reflects virus production, while the data after the peak, i.e., the
down-slopes of the viral load and the infected cells, reflect the
death of infected cells and viral clearance. Thus to reliably esti-
mate the kinetic parameters, one needs to collect time-course data
throughout the infection.
PERSPECTIVE
Our results of an SHIV infection in an in vitro cell culture are
a simple example of a quantitative analysis of virus infection
dynamics employing on mathematical and computational meth-
ods. Our approach can be applied regardless of viral family and
genus. To further explore how our approach of modeling time-
course data can be used in future work we will discuss a number of
hypothetical examples, emphasizing how quantitative estimates
can be used to address unsolved question in virology.
IDENTIFYING THE MAJOR DIFFERENCES AMONG SEVERAL
VIRAL STRAINS
After fitting time-course data from different virus strains, one
can compare the estimated parameters of each viral strain, such
as its half-life of infected cells, burst size and basic reproductive
number, to reveal the quantitatively largest differences between
the strains (Mitchell et al., 2011). For example, let us denote
SHIV-KS661 as “virus-A,” which brings about a half-life of 0.4
days in infected cells, and consider a less cytopathic variant
“virus-B” extending the half-life 1.5-fold to 0.6 days. The expected
time-courses of these two variants are depicted in Figure 4, and
reveal a major difference in the target cell dynamics and minor
differences in the number of infected cells and the viral load
(compare the solid line with the dashed lines, depicting virus A
and B, respectively). If one were to fit the in silico data from virus
A and B in Figure 4 with our mathematical model, one would
correctly conclude that the half-life of infected cells of virus-B
is 1.5 times longer than that of cells infected with virus-A, and
therefore that virus B is less cytopathic than virus A. It is diffi-
cult to arrive at that result by just visual inspection of the data,
however. The effect of cytopathicity on the time courses of target
cells, infected cells, and virus load are difficult to predict intu-
itively. Additionally, there is no experimental technique available
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FIGURE 4 | Predicted virus infection kinetics with different parameters.
The solid curves show the predicted kinetics of target cells (left), infected
cells (middle) and virus load (right) following infection with SHIV-KS661 at an
MOI 2 × 10−4 using the parameters in Tables 2 and 3. The time t = 0
corresponds to 24h after inoculation of SHIV-KS661 to HSC-F. In the text we
call this virus-A. The dashed and dotted curves show those of the variants
virus-B and virus-A∗ , respectively. Virus-B is less cytopathic and has a 1.5-fold
decreased death rate of infected cells (δ = 1.16). Cells infected with the
more virulent “mutant” virus-A∗ die 3-fold faster than those infected with
the wild-type A (i.e., δ = 5.25 vs. δ = 1.75, respectively), but produce 2-fold
more virus (p = 6.72× 104) per day than those infected with “wild-type”
virus-A.
to measure quantities like the cytopathicity directly as an abso-
lute value. For the production rate, the burst size and the basic
reproductive number of the virus, similar arguments apply, and
one has to rely on modeling to identify quantitative differences
between viral strains.
IDENTIFYING THE FUNCTION OF VIRAL PROTEINS OR AMINO
ACIDS IN INFECTION
Using molecular cell biology techniques, we are currently able
to investigate the function of individual viral proteins in sev-
eral aspects of viral replication. However, it remains difficult to
interconnect those particular results and to integrate the roles of
different molecules in terms of the overall parameters defining a
virus infection, like a replication rate or a burst size. By modeling
in vitro time courses, and comparing the estimated parameters
between a wild-type virus and several particular mutants, one can
quantify the role of every amino acid mutation on the several
parameters defining a virus infection. For example, if one were
to take SHIV-KS661 as a “wild-type virus-A,” with an estimated
half-life of infected cells of 0.40 days and a viral production rate of
3.26 × 104 RNA copies per day (see Table 2), and find by fitting
that a more virulent mutant “virus-A∗” has a 3-fold shorter half-
life of its infected cells, but a 2.0-fold increased production rate
of 6.52 × 104 RNA copies per day, one would be able to conclude
that this particular mutation decreases the total viral production
per generation to 2/3 of that of the wild-type. Thus, the more
virulent virus is less fit, i.e., has a lower R0, because the total
burst sizes of virus-A and virus-A∗ are 1.87 × 104 and 1.25 × 104
RNA copies per generation, respectively. For the function of the
mutated protein one would be able to conclude that it plays a
role in the production of novel viral particles, and that increased
production apparently brings about a shorter expected life-span
of infected cells. The solid and dotted curves in Figure 4 show
the virus kinetics predicted by Equation (1) for virus-A (solid
line) and virus-A* (dotted line), respectively. Similar approaches
allow us to also investigate the functions of multiple mutations in
possibly several proteins quantitatively.
FINDING THE TARGET OF NOVEL ANTIVIRAL COMPOUNDS
Calculating and comparing parameter estimates in the absence
and presence of an antiviral compound, allows one to investi-
gate the function of the compound in a very similar manner
(Baccam et al., 2006; Beauchemin et al., 2008). For instance, if
the daily viral production rate is reduced to half but the half-
life of infected cells has remained similar, one concludes that
the compound inhibits viral production without affecting cyto-
pathicity. In addition, if a dose-dependent basic reproductive
number, Ro, were obtained, one would estimate how effectively
the compound inhibits total viral replication. From the value of
1 − 1/R0 (Anderson, 1991), one can calculate the critical com-
pound concentration at which the infection should die out. Note
that this value is not the same as the conventional IC50, the half
maximal (50%) inhibitory concentration. Identifying the precise
mode of action of novel compounds may help the development
of novel antiviral drugs.
FUTURE DIRECTION
As discussed above, an approach of combining experiments with
mathematical modeling has broad applications in virology. One
possible extension of our model is to also consider the “eclipse”
phase of the infection of a cell to allow for a period in which
no virus is produced and the cell may have a different death rate
(Baccam et al., 2006; Beauchemin et al., 2008; Iwami et al., 2012).
Another extension is to divide the viral population into infectious
and non-infectious virus, because the virus that is produced by
most of the cells is non-infectious (Schulze-Horsel et al., 2009;
Iwami et al., 2012). In Equation (1), it is assumed all virus is infec-
tious, and the non-infectious fraction is in fact incorporated by a
lower infection rate β. If one were to have data on the amounts
of infectious and non-infectious virions, and/or on the frac-
tion of infected cells in the eclipse phase, one can extend the
mathematical model accordingly and obtain even more detailed
quantification of the characteristics of any virus studied in par-
ticular culture conditions. Furthermore, it is challenging but
very interesting to distinguish cell-free and cell-to-cell infection,
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which are two different mode of viral infection, and to quantify
the efficacy of each mode. Sourisseau et al. reported that in a
continuously shaken culture in a HIV replication assay cell-to-
cell infection is blocked (Sourisseau et al., 2007). Combining
a novel mathematical model including both a cell-free and
a cell-to-cell infection mode, and fitting that to shaken and
non-shaken HIV replication assays, we might be able to quan-
titatively identify the two infection modes. Summarizing, our
method of modeling time courses of viral infection is effec-
tively capable of describing the data, and therefore provides
a new approach of characterizing and comparing viruses in a
quantitative manner to better understand their infection kinetics
under in vivo circumstances.
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